American Podiatric Medical Association Inc

What it reported doing in 2024

Clinical affairs provided podiatric population health resources and education related to "culinary coaching," "fall prevention, clinician, research and community connections," "glp-1 and glp/gip medications in diabetes management, and "treatment considerations of the pregnant and postpartum patient." developed research 101 video offerings for early career podiatrists to learn how to engage in research. Participated in development of peripheral artery disease quality and performance measures with american heart association and american college of cardiology supported podiatrists' participation in the 2024 and 2025 mips performance years.o offered one-on-one support to members with questions regarding mips eligibility, the hardship exception, and finding the best mips measures for them. Provided feedback to the draft podiatry mips value pathway candidate. Provided the resident essentials bundle of education to resident members. Awarded 62 apha student membership scholarships to current podiatric medical students for the 2025 year. Supported the work of the podiatric population health, research, and education committees. Supported writing competition for students and residents to encourage critical discussion surrounding the issues of financial literacy and physician well-being. Research projects to support the podiatric profession are ongoing and several were submitted for peer-reviewed publication. Worked on systematic review related to open versus closed approach to diabetic foot infections. Submitted a letter to the editor of foot and ankle international to support the podiatric profession from a published article attacking podiatry. Supported apma stewarded mips clinical quality measures #126 and #127. Represented podiatry as co-chair on cms's non-pressure ulcers episode-based cost measure clinician expert workgroup. Served as chair of the patient and community education committee with the american heart association's pad collaborative. Supported investigation of a foot exam-related hedis measure. Worked with air on expansion and harmonization of a diabetic foot-related quality measure. Built/maintained relationship with society for interventional radiology, society of vascular surgery, infectious disease society of america, and the alliance of gout awareness. Participated/represented, along with several apma volunteer leaders, with american heart association's peripheral artery disease national action plan collaborative. Advocated for inclusion of podiatrists in the eligibility requirements of the american institute of ultrasound in medicine. Published "concerning rates of laboratory-confirmed antifungal-resistant onychomycosis and tinea pedis: an online survey of podiatrists, united states" in health science reports and "evidence-based opioid education that reduces prescribing: the 10 principles of opioid prescribing in foot and ankle surgery" in the journal of foot and ankle surgery.

Financial Efficiency

• Mission deployment rate: Limited
• Program expense ratio: Limited
• Fundraising efficiency: Limited

Transparency & Controls

• Consistency checks: 90.9%; rating input score 91; 4th percentile among comparable filings
• Pay-setting controls: 6 of 6 controls in place; rating input score 100
  • Compensation committee: Pass
  • Independent consultant: Pass
  • Other Form 990s reviewed: Pass
  • Written employment contract: Pass
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: Limited
• Grant itemization coverage: 77.6%; rating input score 78; 16th percentile among comparable filings
• Major donor itemization: Limited
• Related-party transparency: Limited

Accountability

• Independent voting board: 84.6%; rating input score 85; 18th percentile among comparable filings
• Governance controls: 9 of 9 controls in place; rating input score 100
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: -18.5%; rating input score 5; 5th percentile among comparable filings
• Total-asset coverage ratio: 1.57; rating input score 53; 53rd percentile among comparable filings
• Liabilities to assets ratio: 0.19; rating input score 60; 60th percentile among comparable filings
• Officer compensation ratio: 17.3%; rating input score 6; 6th percentile among comparable filings

Growth

• Program expense growth: Limited
• Revenue growth: -0.4% per year; rating input score 0; 7th percentile among comparable filings
• Asset growth: -0.2% per year; rating input score 0; 10th percentile among comparable filings